Universal Brain has received FDA 510(k) clearance for its Neurotique™ platform, a device designed to assess cognitive and emotional brain function for psychiatric diagnosis and treatment. The platform utilizes a dry EEG baseball cap with EOG electrodes and an integrated digital testing system to measure brain activity via event-related potentials. Founded in 2022, Universal Brain has secured $7.9 million in seed funding and a $2 million grant from the Japanese government, with plans to launch clinically this summer and pursue pharma contracts. AI
IMPACT This FDA clearance for a neurotech device could accelerate the integration of AI-driven diagnostics in mental healthcare, potentially improving treatment accuracy and patient outcomes.
RANK_REASON FDA clearance for a neurotech device for psychiatric assessment.
- Edgemont Partners
- Greg Hajack
- Kazu Okuda
- Leanne Williams
- Nature
- Neurotique™
- Project Amber
- Salma Health
- Santa Clara University
- Stanford
- FDA
- Google X
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
